NDSIB
UTHR icon

North Dakota State Investment Board’s United Therapeutics UTHR Stock Holding History

North Dakota State Investment Board’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683K Buy
1,261
+36
+3% +$20.3K 0.03% 423
2026
Q1 		$726K Sell
1,225
-339
-22% -$169K 0.03% 380
2025
Q4 		$762K Buy
+1,564
New +$728K 0.03% 410

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

North Dakota State Investment Board's UTHR Position: Q2 2026 in Review

North Dakota State Investment Board increased its United Therapeutics (UTHR) stake by 2.9% in Q2 2026, buying an estimated $20.3K and bringing the position to 1,261 shares worth $683K. The position accounts for 0.03% of the portfolio, ranked #423.

North Dakota State Investment Board first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $762K in Q4 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • North Dakota State Investment Board held 1,261 shares of United Therapeutics worth $683K as of Q2 2026.
  • North Dakota State Investment Board bought 36 United Therapeutics shares in Q2 2026, an estimated $20.3K.
  • United Therapeutics made up 0.03% of North Dakota State Investment Board's portfolio in Q2 2026, its #423 holding.
  • North Dakota State Investment Board first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's United Therapeutics position peaked at $762K in Q4 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.